Funding momentum The Roskamp Institute has a reported revenue range of 25M to 50M and recent programmatic grants including a 43K award in June 2026, indicating active funding during the current year. This suggests a receptive environment for partnerships, sponsored research, and grant-funded collaboration opportunities.

Neurodegenerative focus With emphasis on Alzheimer's disease and neuropsychiatric disorders, coupled with new Brain Reserve Index assessment initiatives, identified opportunities exist for contract research, biomarker development, diagnostics collaboration, and clinical studies aligned with neurodegenerative research needs.

Caregiver support Recent partnership with Empath Health to support dementia caregivers highlights a potential for joint programs, digital health tools, education platforms, and caregiver-focused services that can be bundled with research outcomes or deployed as end-user solutions.

Educational and community engagement Collaborations announced with USF, Mote Marine Laboratory, and local schools for experiential learning indicate a channel for outreach programs, sponsored STEM education initiatives, and potential pilot projects that could involve corporate sponsorships or outcomes-driven grants.

Lab and tech capabilities State-of-the-art labs and a diverse tech stack position the institute to offer contract research services, assay development, and data analytics collaborations. Prospects include selling research services, analytic tooling, and technology transfer opportunities to biotech and pharma partners.